Evidence map›Paper›PMID 20031379›Full record

ArticleInternational journal of antimicrobial agents2010

Inhibition of Listeria monocytogenes infection by neurological drugs.

Linda A Lieberman, Darren E Higgins

Abstract read
In one paragraph

Article in International journal of antimicrobial agents, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Clofazimine Reduces the Survival ofACS infectious diseases · 2020
    Article
  4. Review
  5. Review
  6. Review
  7. Curcumin Promotes the Clearance ofFrontiers in immunology · 2017
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Linda A LiebermanDepartment of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA.
Darren E Higgins
Harvard University · US

Funding

Treatments for Nipah Virus InfectionU54AI057159 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KASPER, DENNIS L. · 2003 to 2013
$113.7M
Temporal Requirements for Intracellular PathogenesisR01AI053669 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HIGGINS, DARREN E · 2003 to 2012
$3.5M
Tyrosine kinase and L. monocytogenes infectionF32AI069772 · NIAID · HARVARD MEDICAL SCHOOL · PI LIEBERMAN, LINDA A · 2006 to 2008
$145k
NIAID NIH HHS AI057159NIAID NIH HHS AI53669NIAID NIH HHS AI69772NIAID NIH HHS F32 AI069772NIAID NIH HHS R01 AI053669NIAID NIH HHS U54 AI057159
6 · The paper itself

Abstract

To gain insights into the cellular processes required for intracellular bacterial pathogenesis, we previously developed a generalisable screening approach to identify small molecule compounds that alter Listeria monocytogenes infection. In this report, a small molecule library enriched for compounds affecting neurological functions was screened and 68 compounds that disrupted L. monocytogenes infection of macrophages were identified. Many of these compounds were known antimicrobial agents, however 26 compounds were novel inhibitors of intracellular infection. Two of the compounds chosen for further study, the antipsychotic drug thioridazine and the calcium channel blocker bepridil, exhibited dose-dependent inhibition of vacuolar escape and intracellular replication of L. monocytogenes during infection of murine macrophages. These results suggest that clinically approved neurological drugs may provide a novel source of anti-infective agents that are suitable for development as therapeutics against intracellular bacterial infections.

Indexed as

AnimalsAnti-Bacterial AgentsBepridilColony Count, MicrobialCytosolDrug Evaluation, PreclinicalHumansListeria monocytogenesMacrophagesMiceThioridazineAnti-Bacterial AgentsBepridilThioridazine

Identifiers

PMID20031379
PMCPMC2818453
OpenAlexW2026947679

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.